Effects of cytokines on platelet production from blood and marrow CD34+ cells

Blood

Volumn 91, Issue 3, 1998, Pages 830-843

  Norol, Françoise ^a   Vitrat, Natacha ^a   Cramer, Elisabeth ^a   Guichard, Josette ^a   Burstein, Samuel A ^a   Vainchenker, William ^a   Debili, Najet ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; FIBRINOGEN RECEPTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; RECOMBINANT STEM CELL FACTOR;

ARTICLE; BONE MARROW CELL; CELL ULTRASTRUCTURE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

EID: 0032005215     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.3.830.830_830_843     Document Type: Article

References (50)

1. Becker RP, De Bruyn PP: The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat 145:182, 1976
2. Radley JM, Scurfield G: The mechanism of platelet release. Blood 56:996, 1980
3. Radley JM, Haller CJ: The demarcation membrane system of the megakaryocyte: A misnomer? Blood 60:213, 1982
4. Thiery JB, Bessis M: La genèse des plaquettes à partir des mégacaryocytes observés sur la cellule vivante. C R Acad Sci Paris 242:290, 1956
5. Thiery JB, Bessis M: Mécanisme de la plaquettogenèse. Etude in vitro par la microcinématographie. Rev Hematol 2:162, 1956
6. Behnke O: An electron microscope of the megakaryocyte of the rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat. J Ultra Res 24:412, 1968
7. Zucker-Francklin D, Petursson S: Thrombocytopoiesis: Analysis by membrane tracer and freeze-fracture on fresh human and cultured mouse megakaryocytes. J Cell Biol 99:390, 1984
8. An E, Ogata K, Kuriya S, Nomura T: Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified megakaryocytes. Exp Hematol 22:149, 1994
9. Hagiwara S, Nagasawa T, Nagahisa H, Takizawa M, Osada M, Abe T: Expression of adhesion molecules on cytoplasmic processes of human megakaryocytes. Exp Hematol 24:690, 1996
10. Miyazaki H, Inoue H, Yanagida M, Horie K, Mikayama T, Ohashi H, Nishikawa M, Kozutsumi H, Suzuki T, Sudo T: Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Exp Hematol 20:855, 1992
11. Hunt P, Hokom MM, Hornkohl A, Wiemann B, Rohde M, Arakawa T: The effect of the platelet-derived glycosaminoglycan serglycin on in vitro proplatelet-like process formation. Exp Hematol 21:1295, 1993
12. Hunt P, Hokom MM, Wiemann B, Leven RM, Arakawa T: Megakaryocyte proplatelet-like process formation in vitro is inhibited by serum prothrombin, a process which is blocked by matrix-bound glycosaminoglycans. Exp Hematol 21:372, 1993
13. Choi E, Nichol J, Hokom M, Hornkohl A, Hunt P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85:402, 1995
14. Choi ES, Hokom MM, Bartley TD, Li YS, Ohashi H, Kato T, Nichol JL, Skrine JD, Knudten A, Chen J, Hornkohl A, Grampp G, Cole S, Trail G, Hunt P: Recombinant human megakaryocyte growth and development factor (MGDF), a ligand form of c-mpl, produces functional human platelets in vitro. Stem Cells 95:2973, 1995
15. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
16. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
17. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D: Murine thrombopoietin: Expression cloning, cDNA sequence and stimulation of platelet production in vivo. Nature 369:565, 1994
18. Choi ES, Hokom MM, Chen JL, Skrine J, Faust J, Nichol J, Hunt P: The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br J Haematol 95:227, 1996
19. Ito T, Ishida Y, Kashiwagi R, Kuriya S-I: Recombinant human c-Mpl ligand is not a direct stimulator of proplatelet formation in mature human megakaryocytes. Br J Haematol 94:387, 1996
20. Inoue H, Ishii H, Tsutsumi M, Tahashi N, Sato M, Shimada Y, Kato T, Miyazaki H: Growth factor-induced process formation of megakaryocytes derived from CFU-MK. Br J Haematol 85:260, 1993
21. Leven RM, Rodriguez A: Immunomagnetic bead isolation of megakaryocytes from guinea-pig bone marrow: Effect of recombinant interleukin-6 on size, ploidy and cytoplasmic fragmentation. Br J Haematol 77:267, 1991
22. Dercksen MW, Weismar IS, Richel DJ, Breton-Gorius J, Vainchenker W, Slaper-Cortenbach CM, Pinedo HM, Von dem Borne AEGK, Gerritsen WR, van der Schoot CE: The value of flow cytometric analysis of platelet glycoprotein on CD34 positive cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood 86:3771, 1995
23. Debili N, Wendung N, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W: The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516, 1995
24. Mitjavila MT, Vinci G, Villeval JL, Kieffer N, Henri A, Testa U, Breton-Gorius J, Vainchenker W: Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: Its relationship to type β transforming growth factor (TGF-β). J Cell Physiol 134:93, 1988
25. Jackson CW, Brown LK, Sommerville BC, Lytes SA, Look AT: Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions. Blood 63:768, 1984
26. Broome JD, Jeng MW: Promotion of replication in lymphoid cells by specific thiols and disulfites in vitro. J Exp Med 138:574, 1973
27. Iscove NN, Sieber F: Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Hematol 3:32, 1975
28. Ono K, Alter BP: Effects of low oxygen tension and antioxidants on human erythropoiesis. Exp Hematol 23:1372, 1995
29. Cramer E, Norol F, Guichard J, Breton-Gorius J, Vainchenker W, Debili N: Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 89:2336, 1997
30. Zalipsky S: Chemistry of polyethylene glycol conjugates with biologically active molecules. Ad Drug Deliv Rev 16:157, 1995
31. Choi ES, Hokom MM, Chen J-L, Dwyer E, Skrine J, Rowan C, Hunt P: The role of megakaryocyte growth and development factor (MGDF) in terminal stages of thrombopoiesis. Blood 86:1125a, 1995 (abstr, suppl 1)
32. Ishibashi T, Miller SL, Burstein SA: Type beta transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood 69:1737, 1987
33. Kuter DJ, Gminski DM, Rosenberg RD: Transforming growth factor β inhibits megakaryocyte growth and endomitosis. Blood 79:619, 1992
34. Nichol JL, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J, Skrine JD, Knudten A, Chen J, Trail G, Sleeman L: Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 95:2973, 1995
35. Arriaga M, South K, Cohen JL, Mazur EM: Interrelationship between mitosis and endomitosis in culture of human megakaryocyte progenitor cells. Blood 69:486, 1987
36. Mazur EM, Cohen JL, Bogart L, Mufson RA, Gesner TG, Yang YC, Clark SC: Recombinant gibbon interleukin-3 stimulates megakaryocyte colony growth in vitro from human peripheral blood progenitor cells. J Cell Physiol 136:439, 1988
37. Debili N, Hegyi E, Navarro S, Katz A, Mouthon M, Breton-Gorius J, Vainchenker W: In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. Blood 77:2326, 1991
38. Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, Caneva L, Sarina B, Murphy S, Thomas T, Della Cuna GR: Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89:2679, 1997
39. Nagler A, Eldor A, Naparstek E, Mumcuoglu M, Slavin S, Deutsch VR: Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro. Exp Hematol 23:1268, 1995
40. + cell expansion and expression of lineage markers during liquid culture of human progenitor cells. Stem Cells 13:167, 1995
41. Mazur EM, Basilico D, Newton JL, Cohen JL, Charland C, Sohl PA, Narendran A: Isolation of large numbers of enriched human megakaryocytes from liquid cultures of normal peripheral blood progenitor cells. Blood 76:1771, 1990
42. Goselink HM, van Damme J, Hiemstra PS, Wuyts A, Stolk J, Fibbe WM, Willemze R, Falkenburg JHK: Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. J Exp Med 184:1305, 1996
43. Kaushansky K, Broudy V, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C: Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234, 1995
44. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D: Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87:2162, 1996
45. de Sauvage FJ, Carver-Moore K, Luoh S-M, Ryan A, Dowd M, Eaton DL, Moore MW: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 183:651, 1996
46. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW: Thrombocytopenia in c-mpl-deficient mice. Science 265:1445, 1994
47. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris JM, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/ MGDF in megakaryocyte development. Cell 81:695, 1995
48. Shivdasani RA: Transcription factors in megakaryocyte differentiation and gene expression, in Kuter DJ, Hunt P, Sheridan W, Zucker-Francklin D (eds): Thrombopoiesis and Thrombopoietins. Molecular, Cellular, Preclinical, and Clinical Biology. Totowa, NJ, Humana, 1996, p 189
49. Choi E: Regulation of proplatelet and platelet formation in vitro, in Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D (eds): Thrombopoiesis and Thrombopoietins. Molecular, Cellular, Preclinical, and Clinical Biology. Totowa, NJ, Humana, 1996, p 271
50. Horie K, Miyazaki H, Hagiwara T, Tahara E, Matsumoto A, Kadoya T, Ogami K, Kato T: Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Exp Hematol 25:169, 1997